The truth of what most doctors think about Obamacare is

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
The truth of what most doctors think about Obamacare is frightening

By Jack Dennis
October 1, 2014



What our doctor’s truly think about Obamacare may frighten you.

Most Americans don’t realize there is good reason that only 14 percent of the nation’s 400,000 licensed physicians are still members of the American Medical Association (AMA).

AMA was long the advocate for the nation’s doctors and “abandoned the needs of the physician years ago and has its own agenda,” states Dr. John Tedeschi, a primary-family care doctor in Robbinsville, New Jersey.

“Doctoring just isn’t the same,” Dr. Tedeschi, who has been practicing medicine for more than 30 year says. “The practice of medicine, its costs and medical policies, are now dictated and controlled by groups that don’t know the first thing about medicine, nor the people it serves.”

The AMA, who for decades made their money from physician dues, has been bleeding profusely with membership decline. Membership has declined by over 75,000 since 2002. But somehow, they are reporting growing revenues. In 2012 it was $239 million, with $70 million coming from “Royalty Revenue.”

The AMA is paid, in their partnership with the government, by the medical coding records system they created that is mandated for all doctors and hospitals. They are required to bill the government or private insurance through this system, but the constant changes of the bureaucracies and politics insures a continuing and ever growing cash flow. Forget that it is bankrupting our doctors, slowing our patient care, and creating a whole new variety of grim medical errors. By changing their position for Obamacare, the AMA may be losing credibility with doctors, but they are certainly earning more money.

“At one time, the practice of medicine in America was the envy of the world. Unfortunately, it has now been radically segmented,” Dr. Tedeschi, who lives in Morrisville, PA, indicated.

Dr. Tedeschi explains Obamacare is all about saving money and “where the money IS ultimately spent, is directed to special interest, profit-making organizations.”

The basis of Obamacare’s financial success depends on a formula devised by Ezekiel Emanuel. Emanuel assigns value to people’s lives to distribute health care money among us.

“Benefit to the patient is secondary,” clarifies the doctor. “And physicians have nowhere to turn for help.”

Dr. Tedeschi explained that this radical change has been so choreographed—“better than a Broadway musical”—it happened so “gradually you hardly notice it at first. It’s a slow and deliberate erosion, targeting your family doctor, someone who will soon become a thing of the past.”

“Thanks to politics, insurance companies, special interest groups and other organizations, medicine is changing: the way it’s provided; who it’s provided to; exactly who the providers are; their qualifications; how much it costs and, literally, ‘who lives and who dies,’” the doctor is adamant. “The old saying ‘follow the money’” has never been truer than it is today.

“We’re moving away from the mission of medicine and more towards the business of healthcare, and these two endeavors are not the same thing,” Twila Brase, President of the Citizens’ Council For Health Freeman states. “We’re moving in the wrong direction.”

“When other people hold the dollars, the mission of medicine is compromised,” Brase reminds people frequently. “Whether it’s the government, or an insurance company, the agendas of the people with the money ultimately take precedence over the needs of the patient.”

Now that American physicians have seen enough of Obamacare to draw informed opinions, only 13 percent of them agree with AMA support of the law. Survey results from Jackson & Coker, a national physician recruitment firm confirm this. The AMA spends about $22 million a year since 2010 lobbying for Obamacare.

Despite 70 percent of U.S. doctors indicated they disagreed with the AMA on Obamacare, the White House used a stage propaganda event in the Rose Guard to lie to the American people in 2011. Obama’s staff actually handed out white lab coats to help legitimize the credibility of the health care plan.

Recent surveys of thousands of doctors indicate Obamacare is having a negative impact on healthcare for their patients. Almost 60 percent of doctors think they will most likely retire in the next five years because of the destructive Obama health plan. Doctors who originally voted Obama in 2008 changed their minds and voted against him by totals of over 15 percent.

“We are now told how much time we can spend with each patient,” Dr. Tedeschi explains. Doctor are mandated “what tests we can and cannot request. We are now forced to re-certify more frequently and answer questions, in many cases, unethically, just to serve their (Obamacare) financial needs.”

“We are told what kind of treatment can be provided to older patients, a type of ‘too old to treat’ approach because of the life expectancy of the patient and the cost to the federal government,” claims Dr. Tedeschi. With Obamacare, age 75 seems to be the magic age of when government healthcare declines for the benefit of the plan and not the patient.

“Even prescription medications that will effectively help the patient are routinely rejected by insurance companies and Medicare in favor of less expensive, ‘generic’ drugs that are archaic and simply don’t do the job,” Dr. Tedeschi states. “And we are aware, of course, of the conflict of interest of insurance companies having stock in the drugs that they do approve. It’s really sad.”

http://www.examiner.com/article/the-truth-of-...rightening
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 401

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 239

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 659

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 157

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 508

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 499

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 281

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 440

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 253

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 282

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading

Top 5 Most Recently Viewed Articles

Antengene's XPOVIO® Gains Approval in Thailand for Cancer Treatment

Updated Category News Views 114

Antengene's Recent Approval of XPOVIO® in Thailand Antengene Corporation Limited, a distinguished global biopharmaceutical company, has reached a notable achievement with the approval of XPOVIO® (selinexor) by the Thailand Food and Drug Administration. This approval marks XPOVIO® as the first and only XPO1 inhibitor authorized for sale in the Thai market. The drug,...

Continue Reading
Monumental Pediatric Surgery Advances at Nicklaus Children

Updated Category News Views 23

Redefining Pediatric Surgery with Mixed Reality Cue the drumroll, because Nicklaus Children's Hospital in Miami just pulled off a doozy in the medical field. The region's first pediatric total hip replacement using mixed reality-assisted guidance has taken place, and the ripples from this bad boy could be significant. The Hero of the Hour: Dr. Thomas J. Utset-Ward Dr....

Continue Reading
Contrasting Luxury Real Estate Trends in the U.S. Market

Updated Category News Views 151

The Evolving Landscape of U.S. Luxury Real Estate In the world of luxury real estate, change is the only constant. A recent report sheds light on how the U.S. luxury housing market is adapting to buyer preferences, with 2026 marking an interesting phase in pricing stabilization. Nationally, entry-level luxury prices stand steady at $1.19 million, but the interpretation of...

Continue Reading
Bureau Veritas Explores Potential Merger with SGS

Updated Category News Views 325

Exploring Business Synergies: Bureau Veritas and SGS Recent media discussions have shed light on the evolving landscape of Bureau Veritas as it engages in talks with SGS about the possibility of a business merger. This potential union reflects the growing trend within industries to enhance competencies and create greater value through collaboration. Bureau Veritas, a...

Continue Reading
Equifax Engages Investors in September Conferences Overview

Updated Category News Views 133

Equifax Invites Investors to Upcoming Conferences Equifax®, a leading data, analytics, and technology company recognized by its stock symbol EFX on the NYSE, is gearing up to engage with investors through several key conferences this September. This month presents an excellent opportunity for investors to gain insights into the company's strategy and future direction....

Continue Reading